Antibody Drug Conjugates (ADC) Market
According to Intent Market Research, the Antibody Drug Conjugates Market is expected to grow from USD 9.3 billion in 2023-e at a CAGR of 14.7% to touch USD 24.2 billion by 2030. The antibody drug conjugates market is dominated by key players such as Pfizer, Daiichi Sankyo, Seagen, Takeda, Gilead Sciences, Roche, Astellas, ADC Therapeutics, ImmunoGen, AbbVie.